Otitis media vaccine - ID Biomedical
Latest Information Update: 13 Mar 2008
At a glance
- Originator ID Biomedical Corporation
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Otitis media; Otorhinolaryngological infections
Most Recent Events
- 13 Mar 2008 No development reported - Preclinical for Otitis media in Canada (unspecified route)
- 13 Mar 2008 No development reported - Preclinical for Otorhinolaryngological infections in Canada (unspecified route)
- 08 Dec 2005 ID Biomedical Corporation is acquired by GlaxoSmithKline